Photodynamic diagnosis cystoscopy demonstrates greater sensitivity in the detection of BCG-refractor bladder tumors compared with standard white light cystoscopy.
Researchers in The Netherlands compared the surgical approaches in patients with muscle-invasive or high-risk nonmuscle-invasive bladder cancer.
Before PDD TURBT can be adopted into clinical practice, a large pragmatic trial is needed, according to investigators.
Among patients with high-risk pTa bladder cancer, female sex was significantly associated with a higher risk for stage progression compared with male sex.
The investigators found no significant age-related differences in survival from muscle-invasive bladder cancer.
Full approval was granted based on overall survival data from a confirmatory trial.
Improvements were seen regardless of PD-L1 expression.
A statement recommends including cancer patients and survivors in COVID-19 vaccine trials.
Patient advocate Marlena Murphy provides a patient’s perspective on GRASP.
GRASP co-founder Julia Maués explains how the initiative came about and reveals plans for the future.
There was a significant improvement in progression-free survival with bevacizumab, but it was not considered clinically meaningful.
The aim of the trial was to determine if adjuvant atezolizumab improved disease-free survival.
New guidelines recommend using the full approved doses of immunotherapy and targeted therapies for patients with cancer and obesity.
Black cancer patients were 44% less likely than White patients to enroll in a portal that provides access to electronic health records.
A decrease in obesity rates may reduce the burden of gallbladder and biliary tract cancer worldwide, according to the results of a study.
Compared with no ureteroscopy or percutaneous biopsy, ureteroscopic biopsy in patients with upper tract urothelial carcinoma was significantly associated with a 40% increased risk for intravesical recurrence of disease.
Complete transurethral resection of bladder tumor prior to neoadjuvant chemotherapy in patients scheduled to undergo radical cystectomy for muscle-invasive bladder is associated with improved overall and cancer-specific survival, a study found.
In current urological practice, clinicians decide whether to place a ureteral stent or nephrostomy, but evidence-based treatment guidance is needed.
The accelerated approval was based on data from the multicenter, open-label, phase 2 TROPHY study.
Seminal vesicle-sparing radical cystectomy improved functional results over a median of 64 months without compromising oncologic outcomes, according to investigators.